Jorge Conde

Jorge Conde is a General Partner at Andreessen Horowitz, a position held since 2017, focusing on investments at the intersection of biology, computer science, and engineering. Additionally, Jorge serves on the boards of multiple companies, including IDRx, Vicinitas Therapeutics, Cartography Biosciences, Tome Biosciences, Dyno Therapeutics, Komodo Health, Octant, Asimov, and CAMP4 Therapeutics. Jorge holds an MBA from Harvard Business School and a Master of Science in the Biomedical Enterprise Program from the Massachusetts Institute of Technology, along with a Bachelor of Arts in Biology from The Johns Hopkins University.